title: Aripiprazole in the treatment of olanzapine-resistant psychotic and motor symptoms of Huntington's disease.
authors.forename: Panagiotis
authors.initials: P
authors.lastname: Oulis
authors.forename: Iraklis
authors.initials: I
authors.lastname: Mourikis
authors.forename: George
authors.initials: G
authors.lastname: Konstantakopoulos
authors.forename: Sokratis G
authors.initials: SG
authors.lastname: Papageorgiou
authors.forename: Anastasios V
authors.initials: AV
authors.lastname: Kouzoupis
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use; D000068180:Aripiprazole; D001569:Benzodiazepines / Q000627:therapeutic use*; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D010879:Piperazines / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000188:drug therapy*; D015363:Quinolones / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D001569:Benzodiazepines; D000068180:Aripiprazole; D000077152:Olanzapine